Description

Ethyl 4-[2-(4-Methylpiperazinomethyl)Phenyl]-4-Oxobutyrate is a high-purity, advanced pharmaceutical intermediate characterized by its specific piperazine-substituted aromatic structure. This compound is of significant value in medicinal chemistry for its role as a key building block in the synthesis of complex active pharmaceutical ingredients (APIs). It is primarily required by research institutions and pharmaceutical manufacturers engaged in the development of novel therapeutic agents, particularly within the fields of central nervous system (CNS) and oncology research.

Application

• Pharmaceutical Intermediate: A critical precursor in the multi-step synthesis of proprietary drug candidates, especially those targeting neurological receptors.
• Research & Development: Used in medicinal chemistry for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• API Synthesis: Serves as a key building block for constructing complex molecular architectures found in potential antipsychotic or anticancer agents.
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for cGMP production of clinical trial materials.
• Biochemical Research: Employed as a tool compound in biochemical assays to study enzyme inhibition or receptor binding.
• Custom Synthesis: Basis for the custom synthesis of analogs and derivatives for specialized research applications.

Basic Information

Product Name	Ethyl 4-[2-(4-Methylpiperazinomethyl)Phenyl]-4-Oxobutyrate
CAS No.	898762-67-9
Molecular Formula	C18H26N2O3
Molecular Weight	318.41 g/mol
Synonyms	Ethyl 4-oxo-4-[2-[(4-methylpiperazin-1-yl)methyl]phenyl]butanoate; 4-[2-[(4-Methyl-1-piperazinyl)methyl]phenyl]-4-oxobutanoic Acid Ethyl Ester; 898762-67-9; Butanoic acid, 4-oxo-4-[2-[(4-methyl-1-piperazinyl)methyl]phenyl]-, ethyl ester; Ethyl 4-(2-((4-methylpiperazin-1-yl)methyl)phenyl)-4-oxobutyrate
EINECS	Contact for details

Quality Control

Our Ethyl 4-[2-(4-Methylpiperazinomethyl)Phenyl]-4-Oxobutyrate is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical R&D and cGMP applications. A comprehensive Certificate of Analysis (COA) detailing purity, impurities, and physical characteristics is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). The compound may be hygroscopic; keep the container tightly sealed in a dry environment to prevent moisture absorption.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.